PLUS1
Period:
Draw Mode:
| Volume | 259,674 |
|
|||||
| News | - | ||||||
| Day High | 8.61 | Low High |
|||||
| Day Low | 8.29 | ||||||
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Evolus Inc | EOLS | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
|
|
|---|---|---|---|---|
| -0.243 | -2.89% | 8.167 | 07:50:29 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 8.50 | 8.29 | 8.61 | 8.42 | 8.41 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,143 | 259,674 | US$ 8.48 | US$ 2,202,575 | - | 6.51 - 14.34 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 07:50:29 | formt | 165 | US$ 8.167 | USD |
Evolus Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 460.71M | 56.41M | 55.64M | US$ 148.62M | US$ -73.98M | -1.33 | -6.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | -3.90M | 3.10% |
Evolus News
| Date | Time | Source | News Article |
|---|---|---|---|
| 17/3/2023 | 10:03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 17/3/2023 | 10:03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 14/3/2023 | 00:01 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 09/3/2023 | 09:14 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) |
| 09/3/2023 | 08:43 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) |
| 09/3/2023 | 08:38 | Edgar (US Regulatory) | Annual Report (10-k) |
| 09/3/2023 | 08:05 | Business Wire | Evolus Reports Fourth Quarter and Full Year 2022 Results and.. |
| 01/3/2023 | 00:45 | Business Wire | Evolus to Participate in the Barclays Global Healthcare.. |
| 28/2/2023 | 00:45 | Business Wire | Evolus Initiates Nuceiva® Launch in Germany and Austria |
| 23/2/2023 | 08:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 23/2/2023 | 00:45 | Business Wire | Evolus to Report Fourth Quarter and Year End 2022 Results.. |
| 22/2/2023 | 08:01 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) |
Historical EOLS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.54 | 8.92 | 8.18 | 8.54 | 512,367 | -0.373 | -4.37% |
| 1 Month | 9.25 | 9.41 | 7.93 | 8.69 | 429,244 | -1.08 | -11.71% |
| 3 Months | 7.01 | 11.49 | 6.51 | 9.19 | 565,258 | 1.16 | 16.5% |
| 6 Months | 9.50 | 11.49 | 6.51 | 8.55 | 474,640 | -1.33 | -14.03% |
| 1 Year | 11.48 | 14.34 | 6.51 | 9.99 | 487,758 | -3.31 | -28.86% |
| 3 Years | 3.76 | 17.38 | 2.85 | 8.26 | 669,534 | 4.41 | 117.21% |
| 5 Years | 11.86 | 39.50 | 2.85 | 11.91 | 643,908 | -3.69 | -31.14% |